Stay updated on Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe footer identifies the site as revision v3.8.0 instead of v3.7.2; the study record still displays a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedAn NIH-wide notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The clinical study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer's site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, indicating access to the study record is blocked rather than presenting the study details.SummaryDifference18%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a software or content management update to the study record page.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.